Talk Bio

Actionable Insights Powered by AI

Subscribe

KEYNOTE-671

ESMO 2025 KEYNOTE-671 Update: Perioperative Pembrolizumab Reinforces NSCLC Standard

talkbio0Tagged , , , , , , , , ,

KEYNOTE-671; pembrolizumab; KEYTRUDA; perioperative immunotherapy; NSCLC; overall survival; event-free survival; ESMO Congress; standard of care

Read More